[Funding alert] Boston-based Quantum Simulation Technologies Secures $2.5M in Funding

The other investors in this round are UTokyo IPC and Kyoto iCAP. The proceeds will support QSimulate's rapidly expanding business centered on its quantum physics-based drug-discovery platform, QSP Life. QSP Life currently includes QUELO, QuValent, and QuantumFP.

Read also - San Francisco-based Every.io Secures $9.5M in Seed Funding

QSimulate uses proprietary quantum physics-based algorithms to faithfully predict answers to large-scale biological problems. QSimulate's technology in its products, such as QUELO and QuValent, have enabled the first quantitative application of quantum mechanics to drug design, providing predictions with unprecedented fidelity, and opening up the computational study of new therapeutic classes.

QSimulate's strategic developments position the company for the digital discovery era. Through the incorporation of physics-based AI, QSimulate's learning models discriminate between AI truth and AI hallucinations in molecular design.

Read also-  NYC-based Hang Secures $9.2M in Series A Round Funding

Niels Nielsen, co-founder of 2xN commented: "We are thrilled to lead the funding round and forge a partnership with QSimulate. Our strategy at 2xN is to back scientists and entrepreneurs who are world leaders in their field and QSimulate is a great example of that.

Their investment in QSimulate is not merely a fiscal alliance; it's an expedition into a quantum-imbued future teeming with endless scientific and industrial revelations. The quantum horizon is vibrant, and with QSimulate, they are not just gazing at it; they are sailing towards it at full steam!"

About QSimulate

Headquartered in Boston, MA, QSimulate is a leader in quantum simulation technology for drug discovery and other industry research and development.

Read also -  Washington-based Nanochon Secure an Investment from Cultivate(MD) Capital Funds

The company offers a range of products and services designed to leverage the power of quantum mechanics to solve industrial-scale problems like never before.